|
|
(1) Chronic heart failure
Despite major advances in the prevention and treatment of cardiac disease, the incidence and prevalence of heart failure continue to rise. This article focuses on the management of chronic heart failure
(PDF 75K)
Pharmaceutical Journal, 7 September 2002, p325-327. Vol 269, no
7214
|
|
(2) Chronic stable angina
Chapter
4 of the National Service Framework for Coronary Heart Disease targets
stable angina. This article focuses on the use of anti-anginal therapies
to manage the symptoms
(PDF 70K)
Pharmaceutical Journal, 14 September 2002, p363-365. Vol 269, no
7215 |
|
(3) Acute coronary syndromes
This
third article in a series on heart disease discusses the management
of acute coronary syndromes, including acute myocardial infarction
(PDF 65K)
Pharmaceutical Journal, 23 November 2002, p747-749. Vol 269, no
7225 |
|
(4) Secondary prevention of heart disease
This
article discusses specific therapeutic interventions that have a
significant impact on cardiovascular risk in coronary heart disease
and reviews the evidence behind their use
(PDF 80K)
Pharmaceutical Journal, 30 November 2002, p784-786. Vol 269, no
7226 |
|
(5) Hypertension
The
fifth article in our series on heart disease looks at the management
of hypertension
(PDF 75K)
Pharmaceutical Journal, 11 January 2003, p52-54. Vol 270, no
7231 |
|
(6) Primary prevention of heart disease
Many people are at risk of
developing coronary heart disease but do not exhibit any signs or symptoms. This article
looks at some interventions that may reduce the risks
(PDF 75K)
Pharmaceutical Journal, 18 January 2003, p86-88. Vol 270, no
7232 |
|
(7) Cholesterol control
Controlling cholesterol levels
in patients with coronary heart disease is a central part of their management plan. This
article discusses lipid-lowering strategies in patients with established CHD or in those
at a high risk of developing CHD
(PDF 55K)
Pharmaceutical Journal, 17 May 2003, p688-690. Vol 270, no
7249 |
|
(8) Arrhythmias: part 1
The
diagnosis and management of cardiac arrhythmias is a complex
process. This article gives a brief overview of common arrhythmias
and highlights strategies, including drug therapies, that may
be considered in their management
(PDF 140K)
Pharmaceutical Journal, 20 September 2003, p368-370. Vol 271, no
7267
(8) Arrhythmias: part 2
This
is the second part of an article about arrhythmias
(PDF 110K)
Pharmaceutical Journal, 18 October 2003, p547-549. Vol 271, no
7271 |
|
(9) Cardiopulmonary resuscitation
This
article is the last in a series on heart disease. It is intended
as a reminder to pharmacists who have
completed a basic life support course. It is also intended to give
an awareness of advanced life support
procedures and how some pharmacists may be involved
(PDF*
110K)
Pharmaceutical Journal, 25 October 2003, p581-583. Vol 271, no
7272 |
|
| • Most
photographs have been removed from the PDF files for copyright reasons.
• The contents of the Pharmaceutical
Journal, associated publications and all PDF files are the property
of the Royal Pharmaceutical Society. See Copyright
for our rights. |
| Photocopies
Photocopies of articles can be ordered from the Society’s library
(library@rpsgb.org.uk);
for details click here |
| Reprints
Details on multiple reprints of the original articles are here |
|
